Levels of flavonoids increase over time in crops grown in organically farmed fields, according to a rare long-term study scheduled for publication in the July 18 issue of ACS?s Journal of Agricultural and Food Chemistry a bi-weekly publication.
When a cell is seriously stressed, say by a heart attack, stroke or cancer, a protein called Bak just may set it up for suicide, researchers have found.
Hispanic women with hypertension and coronary artery disease respond better to drug regimens aimed at controlling high blood pressure than non-Hispanic white women, University of Florida researchers report.
Measuring levels of a chemical found in blood offers the best indicator yet of the amount of fat surrounding abdominal organs, according to a new study of lean and obese individuals reported in the July issue of Cell Metabolism, a publication of Cell Press.
A daily pinta or a helping of dairy foods protect against the clustering of abnormal body chemistry known as the metabolic syndrome, suggests a study in the Journal of Epidemiology and Community Health .
While the overall cost-effectiveness of Medicare benefits have been much-debated, new data now show that people who were uninsured before receiving benefits at age 65 required more intensive and costlier care than those who had been privately insured prior to receiving Medicare.
Those with heavy hearts ? in the literal not figurative sense ? long have been known to be prone to cardiac arrest and sudden death. But many are not, and who among them is subject to serious risk is a mystery.
New evidence published on bmj.com confirms that hormone replacement therapy (HRT) should not be prescribed to older women who are many years past menopause to help prevent chronic conditions such as heart disease.
New research published in Psychophysiology finds a relationship between increased blood pressure and decreased pain perception in a variety of circumstances, including among individuals with heart disease.
Far fewer rheumatoid arthritis patients treated with the drug hydroxychloroquine (HCQ) went on to develop diabetes compared to those who never took the drug, according to a 20-plus-year University of Pittsburgh School of Medicine-led study reported today in the Journal of the American Medical Association.